Search

everythinglearnresearchcommunity

for

Search:↓

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Long-read RNA sequencing can identify complex gene changes in IFAP syndrome.

Fragile hair in children is rarely linked to trichothiodystrophy (TTD).

Baricitinib was effective in treating both early and late onset alopecia areata.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

TTD symptoms vary widely, requiring thorough evaluations.

TIP39 and PTH2R help control calcium levels and skin cell development.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Trichotillomania was successfully treated with risperidone and naltrexone.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

TTD hair brittleness is caused by multiple structural abnormalities.

The infant was diagnosed with Rothmund-Thomson syndrome, a rare genetic disorder causing various physical and developmental issues.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Some burn patients grew extra hair in areas treated with pressure garments or silicone.

Trichotillomania is an obsessive-compulsive disorder causing hair pulling, needing complex treatment to prevent serious issues.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.